Skip to content

Beneficient BENF Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on available-for-sale securities at other companies

Healthcare Services Group logo
Healthcare Services GroupHCSG
-$387K-177%
GigaCloud Technology logo
GigaCloud TechnologyGCT
-$8K-33.3%
Inogen logo
InogenINGN
$17K
Simulations Plus logo
Simulations PlusSLP
-$6K
TFS Financial logo
TFS FinancialTFSL
-$1.91M-136%
GeneDx Holdings logo
GeneDx HoldingsWGS
-$253K-437%

Other financials

Income statement

See full
Revenue$18.7M+322%
Operating income$3.9M+141%
Net income$19.9M+331%
EPS (diluted)-$0.49+26.5%

Balance sheet

See full
Cash & equivalents$7.9M+87.3%
Total debt$100.3M-16.6%
Total equity-$128.6M-1,002%
Total assets$337.9M-15.5%

Cash flow

See full
Operating cash flow-$9.4M+6.3%
CapEx$96.0K-85.5%
Free cash flow-$9.4M+6.7%

Valuation

See full
Market cap$52.86M+2,018%
Enterprise value$145.33M+40.6%

Profitability

See full
Operating margin548.5%-323pp
Net margin517.9%-235pp
FCF margin156.8%-40.4pp

Returns & leverage

See full
Return on equity-1,647.1%-2,080pp
Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's unrealized gains (losses) on available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beneficient's unrealized gains (losses) on available-for-sale securities?
Beneficient (BENF) reported unrealized gains (losses) on available-for-sale securities of -$38K in Q4 2025.
How has Beneficient's unrealized gains (losses) on available-for-sale securities changed year-over-year?
Beneficient's unrealized gains (losses) on available-for-sale securities increased by 68.3% year-over-year, from -$120K to -$38K.
What is the long-term trend for Beneficient's unrealized gains (losses) on available-for-sale securities?
Over 2 years (2023 to 2025), Beneficient's unrealized gains (losses) on available-for-sale securities has grown at a -84.3% compound annual growth rate (CAGR), from $11.23M to -$278K.
What does unrealized gains (losses) on available-for-sale securities mean?
This metric measures the change in the fair value of available-for-sale debt or equity securities that has not yet been realized through a sale. It reflects market-driven fluctuations in the value of the company's investment portfolio that are recorded in equity rather than net income. This provides insight into the unrealized volatility of the firm's balance sheet assets.